WHO Alert: The Drugs Department sealed containers of Coldrif cough syrup during a raid in Chhindwara, Madhya Pradesh, on Sunday. Several children have died in Madhya Pradesh after allegedly consuming adulterated cough syrup. The issue is rapidly gaining momentum. Consequently, the World Health Organization (WHO) has advised caution with three cough syrups.
WHO Warning
The World Health Organization (WHO) has detected three cough syrups in India and urged authorities to notify the health agency if they find any such syrups in their country. For your information, Coldrif syrup, which faced widespread protests after the deaths of children, is one of these three syrups.
Beware of Three Cough Syrups
The global health agency has reportedly issued a warning regarding specific batches of Srisan Pharmaceuticals’ Coldrif, Rednex Pharmaceuticals’ Respifresh TR, and Shape Pharma’s Relife. For your information, these syrups identified by the World Health Organization in India may pose a serious risk. The World Health Organization will issue a global medical product alert based on information received from India.
Government Issues Advisory
Following the deaths of children, the government issued an advisory advising caution when administering cough syrups to children. According to this advisory, such medicines should not be given to children under 2 years of age. The Indian Health Authority has clarified that no contaminated medicines were exported from India, and the United States has also confirmed that toxic cough syrups were not shipped to them.
